Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Lindblad KE"'
Autor:
Lindblad KE; Icahn School of Medicine at Mount Sinai, New York, United States., Donne R; Icahn School of Medicine at Mount Sinai, New York, United States., Liebling I; Icahn School of Medicine at Mount Sinai, New York, United States., Barcena-Varela M; Icahn School of Medicine at Mount Sinai, New York, NY, United States., Lozano A; Icahn School of Medicine at Mount Sinai, New York, United States., Ruiz de Galarreta M; Icahn School of Medicine at Mount Sinai, New York, New York, United States., Dhainaut M; Icahn School of Medicine at Mount Sinai, New York, United States., Param NJ; Icahn School of Medicine at Mount Sinai, New York, United States., Giotti B; Icahn School of Medicine at Mount Sinai, New York, NY, United States., Cappuyns S; University Hospitals Leuven, Leuven, Leuven, Belgium., Kodama T; Osaka University, Graduate School of Medicine, Suita, Osaka, Japan., Wang Y; Genentech, Inc., South San Francisco, CA, United States., Kamphorst AO; Icahn School of Medicine at Mount Sinai, New York, United States., Tsankov AM; Icahn School of Medicine at Mount Sinai, New York, NY, United States., Lujambio A; Icahn School of Medicine at Mount Sinai, New York, United States.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Nov 19. Date of Electronic Publication: 2024 Nov 19.
Autor:
Lindblad KE, Donne R, Liebling I, Bresnahan E, Barcena-Varela M, Lozano A, Park E, Giotti B, Burn O, Fiel MI, Bravo-Cordero JJ, Tsankov AM, Lujambio A
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Oct 27. Date of Electronic Publication: 2024 Oct 27.
Autor:
Piqué-Gili M; Liver Cancer Translational Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Andreu-Oller C; Liver Cancer Translational Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Mesropian A; Liver Cancer Translational Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Esteban-Fabró R; Liver Cancer Translational Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Bárcena-Varela M; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine, Department of Pathology), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Ruiz de Galarreta M; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine, Department of Pathology), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Montironi C; Liver Cancer Translational Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain.; Pathology Department & Molecular Biology CORE, Biomedical Diagnostic Center, Barcelona Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain., Martinez-Quetglas I; Liver Cancer Translational Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Cappuyns S; Digestive Oncology, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.; Laboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Human Genetics, VIB and KU Leuven, Leuven, Belgium.; VIB Centre for Cancer Biology, Leuven, Belgium., Peix J; Liver Cancer Translational Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Keraite I; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine, Department of Pathology), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Gris-Oliver A; Liver Cancer Translational Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Fernández-Martínez E; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine, Department of Pathology), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Mauro E; Liver Cancer Translational Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Torres-Martin M; Liver Cancer Translational Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Abril-Fornaguera J; Liver Cancer Translational Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Lindblad KE; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine, Department of Pathology), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Lambrechts D; Laboratory for Translational Genetics, Department of Human Genetics, VIB and KU Leuven, Leuven, Belgium.; VIB Centre for Cancer Biology, Leuven, Belgium., Dekervel J; Digestive Oncology, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.; Laboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven, Leuven, Belgium., Thung SN; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine, Department of Pathology), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Sia D; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine, Department of Pathology), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Lujambio A; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine, Department of Pathology), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Pinyol R; Liver Cancer Translational Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain., Llovet JM; Liver Cancer Translational Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain.; Mount Sinai Liver Cancer Program (Divisions of Liver Diseases, Department of Hematology/Oncology, Department of Medicine, Department of Pathology), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain.
Publikováno v:
JHEP reports : innovation in hepatology [JHEP Rep] 2024 Sep 07; Vol. 6 (11), pp. 101212. Date of Electronic Publication: 2024 Sep 07 (Print Publication: 2024).
Autor:
Chen Z; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. zhihong.chen@mssm.edu.; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA. zhihong.chen@mssm.edu.; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA. zhihong.chen@mssm.edu., Soni N; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Pinero G; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Giotti B; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Eddins DJ; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA.; Department of Medicine, Lowance Center for Human Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, 30322, USA., Lindblad KE; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Ross JL; Emory University Department of Microbiology and Immunology, Emory Vaccine Center, Atlanta, GA, 30322, USA., Puigdelloses Vallcorba M; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Joshi T; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Angione A; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Thomason W; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Keane A; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Tsankova NM; Department of Pathology and Laboratory Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Gutmann DH; Department of Neurology, Washington University School of Medicine, St. Louis, MO, 63110, USA., Lira SA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Lujambio A; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Ghosn EEB; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA.; Department of Medicine, Lowance Center for Human Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, 30322, USA., Tsankov AM; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Hambardzumyan D; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. dolores.hambardzumyan@mssm.edu.; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA. dolores.hambardzumyan@mssm.edu.; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA. dolores.hambardzumyan@mssm.edu.; Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. dolores.hambardzumyan@mssm.edu.
Publikováno v:
Nature communications [Nat Commun] 2023 Apr 03; Vol. 14 (1), pp. 1839. Date of Electronic Publication: 2023 Apr 03.
Autor:
Martin-Serrano MA; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Kepecs B; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Torres-Martin M; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain., Bramel ER; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Haber PK; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Merritt E; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; The Precision Immunology Institute (PrIISM), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Rialdi A; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Param NJ; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Maeda M; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Lindblad KE; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; The Precision Immunology Institute (PrIISM), Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Carter JK; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Barcena-Varela M; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; The Precision Immunology Institute (PrIISM), Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Mazzaferro V; General Surgery and Liver Transplantation Unit, Department of Oncology and Hemato-Oncology, University of Milan and Istituto Nazionale Tumori, IRCCS Foundation, Milano, Lombardia, Italy., Schwartz M; Department of Surgery, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Affo S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain., Schwabe RF; Department of Medicine, Columbia University, New York, New York, USA., Villanueva A; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Guccione E; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Friedman SL; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Lujambio A; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; The Precision Immunology Institute (PrIISM), Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Tocheva A; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; The Precision Immunology Institute (PrIISM), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Llovet JM; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Thung SN; Department of Pathology, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Tsankov AM; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Sia D; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA daniela.sia@mssm.edu.
Publikováno v:
Gut [Gut] 2023 Apr; Vol. 72 (4), pp. 736-748. Date of Electronic Publication: 2022 May 18.
Autor:
Tsai CH; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei City, Taiwan., Chuang YM; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland., Li X; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland., Yu YR; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland., Tzeng SF; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei City, Taiwan., Teoh ST; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA., Lindblad KE; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, USA., Di Matteo M; Laboratory of Tumor Inflammation and angiogenesis, Vesalius Research Center, VIB, Leuven, Belgium; Laboratory of Tumor Inflammation and angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium., Cheng WC; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland., Hsueh PC; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland., Kao KC; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland., Imrichova H; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Wien, Austria., Duan L; Department of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, NC, USA., Gallart-Ayala H; Metabolomics Platform, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland., Hsiao PW; Agricultural Biotechnology Research Center, Academia Sinica, Taipei City, Taiwan., Mazzone M; Laboratory of Tumor Inflammation and angiogenesis, Vesalius Research Center, VIB, Leuven, Belgium; Laboratory of Tumor Inflammation and angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium., Ivanesevic J; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Wien, Austria., Liu X; Department of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, NC, USA., de Visser KE; Division of Tumor Biology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lujambio A; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, USA., Lunt SY; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA; Department of Chemical Engineering and Materials Science, Michigan State University, East Lansing, MI, USA., Kaech SM; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA, USA., Ho PC; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland. Electronic address: ping-chih.ho@unil.ch.
Publikováno v:
Cell metabolism [Cell Metab] 2023 Jan 03; Vol. 35 (1), pp. 118-133.e7.
Autor:
Lindblad KE; Department of Oncological Sciences , Icahn School of Medicine at Mount Sinai , New York , New York , USA.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine , Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , New York , New York , USA.; The Precision Immunology Institute , Icahn School of Medicine at Mount Sinai , New York , New York , USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai , New York , New York , USA., Lujambio A; Department of Oncological Sciences , Icahn School of Medicine at Mount Sinai , New York , New York , USA.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine , Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , New York , New York , USA.; The Precision Immunology Institute , Icahn School of Medicine at Mount Sinai , New York , New York , USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai , New York , New York , USA.
Publikováno v:
Hepatology (Baltimore, Md.) [Hepatology] 2023 Jan 01; Vol. 77 (1), pp. 6-9. Date of Electronic Publication: 2022 Jul 10.
Autor:
Goswami M; National Heart Lung and Blood Institute, Bethesda, Maryland, USA.; National Cancer Institute, Bethesda, Maryland, USA., Gui G; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Dillon LW; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Lindblad KE; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Thompson J; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Valdez J; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Kim DY; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Ghannam JY; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Oetjen KA; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Destefano CB; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Smith DM; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Tekleab H; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Li Y; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Dagur P; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Hughes T; National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Marté JL; National Cancer Institute, Bethesda, Maryland, USA., Del Rivero J; National Cancer Institute, Bethesda, Maryland, USA., Klubo-Gwiezdzinksa J; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA., Gulley JL; National Cancer Institute, Bethesda, Maryland, USA., Calvo KR; National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Lai C; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Hourigan CS; National Heart Lung and Blood Institute, Bethesda, Maryland, USA hourigan@nih.gov.; Trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, Maryland, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jan; Vol. 10 (1).
Autor:
Dillon LW; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Ghannam J; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Nosiri C; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Gui G; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Goswami M; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Calvo KR; Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland., Lindblad KE; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Oetjen KA; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Wilkerson MD; Precision Medicine Initiative for Military Medical Research and Education, Uniformed Services University of the Health Sciences, Bethesda, Maryland.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland.; Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, Maryland., Soltis AR; Precision Medicine Initiative for Military Medical Research and Education, Uniformed Services University of the Health Sciences, Bethesda, Maryland.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland., Sukumar G; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland.; The American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, Maryland., Dalgard CL; Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, Maryland.; The American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, Maryland., Thompson J; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Valdez J; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., DeStefano CB; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Lai C; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Sciambi A; Mission Bio, Inc., South San Francisco, California., Durruthy-Durruthy R; Mission Bio, Inc., South San Francisco, California., Llanso A; Mission Bio, Inc., South San Francisco, California., Gulati S; Mission Bio, Inc., South San Francisco, California., Wang S; Mission Bio, Inc., South San Francisco, California., Ooi A; Mission Bio, Inc., South San Francisco, California., Dagur PK; Flow Cytometry Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., McCoy JP; Flow Cytometry Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Burr P; DNA Sequencing and Genomics Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Li Y; DNA Sequencing and Genomics Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Hourigan CS; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. hourigan@nih.gov.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2021 Jul; Vol. 2 (4), pp. 319-325. Date of Electronic Publication: 2021 May 25.
Autor:
Qing T; Breast Medical Oncology, Yale School of Medicine, New Haven, CT 06511, USA., Jun T; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Lindblad KE; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Lujambio A; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Marczyk M; Breast Medical Oncology, Yale School of Medicine, New Haven, CT 06511, USA.; Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland., Pusztai L; Breast Medical Oncology, Yale School of Medicine, New Haven, CT 06511, USA., Huang KL; Department of Genetics and Genomic Sciences, Center for Transformative Disease Modeling, Tisch Cancer Institute, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2021 May 18; Vol. 2 (5), pp. 100276. Date of Electronic Publication: 2021 May 18 (Print Publication: 2021).